415 related articles for article (PubMed ID: 25680303)
41. Hematopoietic stem cells are pluripotent and not just "hematopoietic".
Ogawa M; LaRue AC; Mehrotra M
Blood Cells Mol Dis; 2013 Jun; 51(1):3-8. PubMed ID: 23453528
[TBL] [Abstract][Full Text] [Related]
42. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.
Sturgeon CM; Ditadi A; Awong G; Kennedy M; Keller G
Nat Biotechnol; 2014 Jun; 32(6):554-61. PubMed ID: 24837661
[TBL] [Abstract][Full Text] [Related]
43. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
[TBL] [Abstract][Full Text] [Related]
44. Modeling human hematopoietic cell development from pluripotent stem cells.
Kardel MD; Eaves CJ
Exp Hematol; 2012 Aug; 40(8):601-11. PubMed ID: 22510344
[TBL] [Abstract][Full Text] [Related]
45. Hematopoietic development from human induced pluripotent stem cells.
Lengerke C; Grauer M; Niebuhr NI; Riedt T; Kanz L; Park IH; Daley GQ
Ann N Y Acad Sci; 2009 Sep; 1176():219-27. PubMed ID: 19796250
[TBL] [Abstract][Full Text] [Related]
46. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
[TBL] [Abstract][Full Text] [Related]
47. Efficient production of T cells from mouse pluripotent stem cells by controlled expression of Lhx2.
Kitajima K; Kawaguchi M; Miyashita K; Nakajima M; Kanokoda M; Hara T
Genes Cells; 2015 Sep; 20(9):720-38. PubMed ID: 26153538
[TBL] [Abstract][Full Text] [Related]
48. Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cells.
Shan W; Yu Q; Long Y; Luo Q; Li H; Han Y; Xu Y; Fu S; Zeng X; Wei C; Gao Y; Li X; Li X; Zhang L; Liu L; Chen M; Qian P; Huang H
Stem Cell Res Ther; 2021 Jun; 12(1):353. PubMed ID: 34147128
[TBL] [Abstract][Full Text] [Related]
49. Concise review: programming human pluripotent stem cells into blood.
Easterbrook J; Fidanza A; Forrester LM
Br J Haematol; 2016 Jun; 173(5):671-9. PubMed ID: 26996518
[TBL] [Abstract][Full Text] [Related]
50. On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium.
Long Y; Huang H
Sci China Life Sci; 2015 Dec; 58(12):1256-61. PubMed ID: 26612042
[TBL] [Abstract][Full Text] [Related]
51. Comparative transcriptomics of hepatic differentiation of human pluripotent stem cells and adult human liver tissue.
Ghosheh N; Küppers-Munther B; Asplund A; Edsbagge J; Ulfenborg B; Andersson TB; Björquist P; Andersson CX; Carén H; Simonsson S; Sartipy P; Synnergren J
Physiol Genomics; 2017 Aug; 49(8):430-446. PubMed ID: 28698227
[TBL] [Abstract][Full Text] [Related]
52. Haematopoietic stem and progenitor cells from human pluripotent stem cells.
Sugimura R; Jha DK; Han A; Soria-Valles C; da Rocha EL; Lu YF; Goettel JA; Serrao E; Rowe RG; Malleshaiah M; Wong I; Sousa P; Zhu TN; Ditadi A; Keller G; Engelman AN; Snapper SB; Doulatov S; Daley GQ
Nature; 2017 May; 545(7655):432-438. PubMed ID: 28514439
[TBL] [Abstract][Full Text] [Related]
53. R-spondin2 promotes hematopoietic differentiation of human pluripotent stem cells by activating TGF beta signaling.
Wang Y; Gao J; Wang H; Wang M; Wen Y; Guo J; Su P; Shi L; Zhou W; Zhou J
Stem Cell Res Ther; 2019 May; 10(1):136. PubMed ID: 31109354
[TBL] [Abstract][Full Text] [Related]
54. Engineered Murine HSCs Reconstitute Multi-lineage Hematopoiesis and Adaptive Immunity.
Lu YF; Cahan P; Ross S; Sahalie J; Sousa PM; Hadland BK; Cai W; Serrao E; Engelman AN; Bernstein ID; Daley GQ
Cell Rep; 2016 Dec; 17(12):3178-3192. PubMed ID: 28009288
[TBL] [Abstract][Full Text] [Related]
55. Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions.
Fukuda T; Takayama K; Hirata M; Liu YJ; Yanagihara K; Suga M; Mizuguchi H; Furue MK
Exp Cell Res; 2017 Mar; 352(2):333-345. PubMed ID: 28215634
[TBL] [Abstract][Full Text] [Related]
56. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
Kaufman DS
Blood; 2009 Oct; 114(17):3513-23. PubMed ID: 19652198
[TBL] [Abstract][Full Text] [Related]
57. In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.
Smith MJ; Webber BR; Mohtashami M; Stefanski HE; Zúñiga-Pflücker JC; Blazar BR
Stem Cells; 2015 Nov; 33(11):3174-80. PubMed ID: 26227158
[TBL] [Abstract][Full Text] [Related]
58. Hematopoietic development from human embryonic stem cells.
Bhatia M
Hematology Am Soc Hematol Educ Program; 2007; ():11-6. PubMed ID: 18024603
[TBL] [Abstract][Full Text] [Related]
59. Assessment of the Hematopoietic Differentiation Potential of Human Pluripotent Stem Cells in 2D and 3D Culture Systems.
Mora-Roldan GA; Ramirez-Ramirez D; Pelayo R; Gazarian K
Cells; 2021 Oct; 10(11):. PubMed ID: 34831080
[TBL] [Abstract][Full Text] [Related]
60. The safety of human pluripotent stem cells in clinical treatment.
Simonson OE; Domogatskaya A; Volchkov P; Rodin S
Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
